Your browser doesn't support javascript.
loading
The added value of H2 antagonists in premedication regimens during paclitaxel treatment.
Cox, Juul M; van Doorn, Leni; Malmberg, Ruben; Oomen-de Hoop, Esther; Bosch, Tessa M; van den Bemt, Patricia M L A; Boere, Ingrid A; Jager, Agnes; Mathijssen, Ron H J; van Leeuwen, Roelof W F.
Afiliação
  • Cox JM; Department of Clinical Pharmacy and Maasstad Lab, Maasstad Hospital, Rotterdam, The Netherlands.
  • van Doorn L; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Malmberg R; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Oomen-de Hoop E; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Bosch TM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • van den Bemt PMLA; Department of Clinical Pharmacy and Maasstad Lab, Maasstad Hospital, Rotterdam, The Netherlands.
  • Boere IA; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands.
  • Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • van Leeuwen RWF; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Br J Cancer ; 124(10): 1647-1652, 2021 05.
Article em En | MEDLINE | ID: mdl-33762718

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pré-Medicação / Ranitidina / Paclitaxel / Hipersensibilidade a Drogas / Neoplasias Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Br J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pré-Medicação / Ranitidina / Paclitaxel / Hipersensibilidade a Drogas / Neoplasias Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Br J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda
...